# Lidocaine Supplement for Minimal Invasive Parathyroid Surgery

> **NCT00528502** · PHASE3 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Parathyroid Disease

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00528502
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Terminated due to no patient enrollment.
- **Last updated:** 2012-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00528502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00528502, "Lidocaine Supplement for Minimal Invasive Parathyroid Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00528502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*